Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,690 | 23,520 | 20,560 | 21,770 | 19,750 |
| Marketable Securities | 42,460 | 40,450 | 49,250 | 46,170 | 66,020 |
| Receivables | N/A | 8,650 | 4,960 | 6,890 | 0 |
| Inventories | 4,550 | 0 | 0 | 0 | 0 |
| Other current assets | 2,340 | 1,660 | 1,440 | 1,350 | 7,130 |
| TOTAL | $73,040 | $74,280 | $76,210 | $76,180 | $92,900 |
| Non-Current Assets | |||||
| PPE Net | N/A | 64,140 | 63,350 | N/A | N/A |
| Investments And Advances | 27,430 | 24,800 | 28,280 | 38,740 | 30,840 |
| Other Non-Current Assets | 210 | 220 | 160 | 150 | 150 |
| TOTAL | $27,640 | $89,160 | $91,790 | $38,890 | $30,990 |
| Total Assets | $136,990 | $134,380 | $139,830 | $149,320 | $156,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 60 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 6,550 | 4,530 | 4,850 | 6,030 | 5,550 |
| Other current liabilities | 5,320 | 3,140 | 2,720 | 2,730 | 2,730 |
| TOTAL | $13,310 | $8,870 | $8,740 | $9,850 | $9,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,520 | 1,560 | 1,570 | 1,590 | 1,600 |
| aiOther Non-Current Liabilities | 280 | 290 | 290 | 280 | 280 |
| TOTAL | $14,130 | $14,960 | $15,680 | $16,010 | $16,260 |
| Total Liabilities | $27,460 | $23,850 | $24,440 | $25,890 | $25,680 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 30 | 30 | 30 | 30 |
| Retained earnings | -200,300 | -198,920 | -193,990 | -186,160 | -177,230 |
| Other shareholders' equity | -490 | -430 | -440 | -200 | -140 |
| TOTAL | $109,530 | $110,520 | $115,390 | $123,430 | $131,220 |
| Total Liabilities And Equity | $136,990 | $134,370 | $139,830 | $149,320 | $156,900 |